INTERNATIONAL STEM CELL CORPORATION (ISCO) Net margin 2016–2025
INTERNATIONAL STEM CELL CORPORATION (ISCO) net profit margin by fiscal year — reported net income divided by reported revenue.
-4.6%FY2025 · since FY2016: -15.1% → -4.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -4.6% | -2.3 pp |
| FY2024 | -2.3% | -0.6 pp |
| FY2023 | -1.7% | +2.4 pp |
| FY2022 | -4.0% | +8.5 pp |
| FY2021 | -12.5% | +25.7 pp |
| FY2020 | -38.2% | +6.8 pp |
| FY2019 | -45.0% | -25.8 pp |
| FY2018 | -19.2% | +62.2 pp |
| FY2017 | -81.4% | -66.3 pp |
| FY2016 | -15.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice